Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer

被引:0
|
作者
Youdong Mao
Luis Castillo-Menendez
Liping Wang
Christopher Gu
Alon Herschhorn
Anik Désormeaux
Andres Finzi
Shi-Hua Xiang
Joseph G Sodroski
机构
[1] Dana-Farber Cancer Institute,Department of Cancer Immunology and AIDS
[2] Department of Microbiology and Immunobiology Harvard Medical School,Centre de Recherche du Centre Hospitalier de I’Université de Montréal, Department of Microbiology and Immunology
[3] Université de Montréal,Nebraska Center for Virology, School of Veterinary Medicine and Biomedical Sciences
[4] University of Nebraska-Lincoln,Ragon Institute of Massachusetts General Hospital
[5] Massachusetts Institute of Technology,Department of Immunology and Infectious Diseases
[6] and Harvard,undefined
[7] Harvard School of Public Health,undefined
关键词
Human Immunodeficiency Virus; Envelope Glycoprotein; Helical Coil; Helical Bundle; Gp41 Subunit;
D O I
10.1186/1742-4690-10-S1-O1
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins
    Dey, Antu K.
    David, Kathryn B.
    Lu, Min
    Moore, John P.
    VIROLOGY, 2009, 385 (01) : 275 - 281
  • [42] Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
    Derking, Ronald
    Ozorowski, Gabriel
    Sliepen, Kwinten
    Yasmeen, Anila
    Cupo, Albert
    Torres, Jonathan L.
    Julien, Jean-Philippe
    Lee, Jeong Hyun
    van Montfort, Thijs
    de Taeye, Steven W.
    Connors, Mark
    Burton, Dennis R.
    Wilson, Ian A.
    Klasse, Per-Johan
    Ward, Andrew B.
    Moore, John P.
    Sanders, Rogier W.
    PLOS PATHOGENS, 2015, 11 (03) : 1 - 22
  • [43] A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells
    Mark Melchers
    Katie Matthews
    Robert P de Vries
    Dirk Eggink
    Thijs van Montfort
    Ilja Bontjer
    Carolien van de Sandt
    Kathryn David
    Ben Berkhout
    John P Moore
    Rogier W Sanders
    Retrovirology, 8
  • [44] A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells
    Melchers, Mark
    Matthews, Katie
    de Vries, Robert P.
    Eggink, Dirk
    van Montfort, Thijs
    Bontjer, Ilja
    Moore, John P.
    Sanders, Rogier W.
    RETROVIROLOGY, 2011, 8
  • [45] HIV-1 Envelope Glycoprotein Trimer Immunogenicity Elicited in the Presence of Human CD4 Alters the Neutralization Profile
    Forsell, Mattias N. E.
    McKee, Krisha
    Feng, Yu
    Mascola, John R.
    Wyatt, Richard T.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (11) : 1089 - 1098
  • [46] HIV-1 entry stoichiometry differs across strains, distribution of surface envelope (Env) glycoprotein trimer, and inter-protomer cooperativity in Env trimer
    Katte, Revansiddha H.
    Han, Yang
    Hong, Xinyu
    Lu, Maolin
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 66A - 66A
  • [47] Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer
    Zhang, Shijian
    Wang, Kunyu
    Wang, Wei Li
    Nguyen, Hanh T.
    Chen, Shuobing
    Lu, Maolin
    Go, Eden P.
    Ding, Haitao
    Steinbock, Robert T.
    Desaire, Heather
    Kappes, John C.
    Sodroski, Joseph
    Mao, Youdong
    JOURNAL OF VIROLOGY, 2021, 95 (24)
  • [48] Glycosylation in HIV-1 envelope glycoprotein and its biological implications
    Ho, Yung Shwen
    Saksena, Nitin K.
    FUTURE VIROLOGY, 2013, 8 (08) : 783 - 800
  • [49] Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein
    Piai, Alessandro
    Fu, Qingshan
    Cai, Yongfei
    Ghantous, Fadi
    Xiao, Tianshu
    Shaik, Md Munan
    Peng, Hanqin
    Rits-Volloch, Sophia
    Chen, Wen
    Seaman, Michael S.
    Chen, Bing
    Chou, James J.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [50] Conformation of the HIV-1 gp120 envelope glycoprotein
    Sodroski, J
    Wyatt, R
    Olshevsky, U
    Olshevsky, V
    Moore, J
    DEVELOPMENT AND APPLICATIONS OF VACCINES AND GENE THERAPY IN AIDS, 1996, 48 : 184 - 187